Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndrome.

Saved in:
Bibliographic Details
Title: Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndrome.
Authors: Njonou Noujiep SS; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Altmann J; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Berlin, Germany.; National Center for Tumor Diseases (NCT), Berlin, Germany., Sehouli J; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Berlin, Germany.; National Center for Tumor Diseases (NCT), Berlin, Germany.
Source: Frontiers in oncology [Front Oncol] 2026 Apr 20; Vol. 16, pp. 1785547. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2026.1785547